Alzheimer's Drug Approved by Health Canada Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease. Lecanemab aims to slow the early stag…
Wizz Air Revives $580 Pass and Tests Business Class European budget airline Wizz Air has relaunched its popular ‘All You Can Fly’ membersh…
Hong Kong Tennis Open: Last China Players Exit Zhang Shuai and Wang Yafan lost in straight sets, while top seed Belinda Bencic continued h…
EU Tests Reveal Safety Risks in Low-Cost Products EU tests found major safety risks in low-cost products from Shein and Temu, with 69% fai…
Everest Medicines Acquires Exclusive Rights to Novel Biologic for Eye Disorders Everest Medicines has acquired an exclusive license to dev…
Krafton's Shift to AI-First Company PUBG maker Krafton is investing ₩100 billion ($69 million) to become an AI-first company. The c…
DHS Agreement Reveals Risks of Using Social Security Data for Voter Citizenship Checks A recently released agreement gives the Department …
Why Israel Lost the Gaza Opinion War Sacrificial violence crumbles under scrutiny in the modern world. In the war on Gaza, Israel p…
Uncertain Budget Victory for Carney's Liberals With Budget Day approaching, it remains unclear if Mark Carney's Liberals will secure the n…
Implementing Photobiomodulation for Dry AMD Dry age-related macular degeneration progresses slowly but relentlessly, resulting in meaningf…